Search | Hey I See You

Juli Kumari added blog Health
2025-10-29 09:45:11

Global CRISPR Gene Editing Market Size, Share & Growth Forecast 2025-2033
The global CRISPR Gene Editing Market is moving from a promising research domain into a full-scale industry shaping the future of medicine, biotechnology, and even agriculture. According to DataM Intelligence, the market was valued at approximately US$ 4.21 billion in 2023, rising to about US$ 4.67 billion in 2024, and is forecast to reach roughly US$ 12.78 billion by 2033, implying a compound...

0 Comments 0 Shares 0 Reviews

Please log in to like, share and comment!
Juli Kumari added blog Health
2025-10-24 09:24:26

Global CRISPR Gene Editing Market Trends, Opportunities, and Future Outlook
The CRISPR gene editing market has emerged as one of the most transformative segments in biotechnology, enabling precise and programmable modifications to DNA using CRISPR systems such as Cas9, Cas12 and beyond. These technologies are increasingly applied in therapeutic development, agricultural biotech, and research tools, thereby creating a fast-expanding ecosystem of products, services and...

0 Comments 0 Shares 0 Reviews

Please log in to like, share and comment!
Praneetha Vadakattu added blog Health
2025-10-23 12:25:57

Innovations in Cancer Gene Therapy: Key Trends and Market Insights to 2032
The Global Cancer Gene Therapy Market was valued at US$ 2.1 billion in 2023 and is projected to reach US$ 7.8 billion by 2031, registering a CAGR of 17.5% during the forecast period 2024–2031. Market growth is primarily driven by the increasing prevalence of cancer worldwide, coupled with the growing demand for targeted and personalized treatment modalities beyond conventional...

0 Comments 0 Shares 0 Reviews

Please log in to like, share and comment!
Praneetha Vadakattu added blog Wellness
2025-10-08 07:21:37

Manufacturing and Regulatory Evolution in the Cell and Gene Therapy Landscape
The global Cell and Gene Therapy Market was valued at US$ 13.90 Billion in 2024 and is projected to reach US$ 105.83 Billion by 2033, growing at a CAGR of 21.5% during 2025–2033. Growth is being driven by rising prevalence of genetic disorders, cancers, and rare diseases, coupled with advancements in biotechnology, regenerative medicine, and personalized therapeutics. Cell and gene...

0 Comments 0 Shares 0 Reviews

Please log in to like, share and comment!